This week my colleague Antonio Regalado had an interesting update on GLP-1 weight-loss drugs. According to research presented ...

Today’s LLMs are engineered to disobey dangerous requests. But AI refusal is far from foolproof—and could become an ...

Trevor Wischnewsky is making sure that the sky stays organized as we enter the age of food delivery by drone. The moment ...

Join a subscriber-only conversation with one of MIT Technology Review's Innovators Under 35. Available only for MIT ...

Anyone can unfurl the SlamDam on the ground along a riverbank or shoreline and pump it full of water until it swells into place. And there it stands, up to 1.3 meters high, shielding nearby property ...

This week, we released our 2026 version of our Climate Tech Companies to Watch list. It’s an annual project that the MIT ...

Advances in AI offer tantalizing glimpses of a future in which robots navigate the world the way humans do. The question is ...

Popular weight-loss drugs may do more than help people shed pounds. They might also slow the aging process. Drugmakers Eli Lilly and Novo Nordisk say patients taking their GLP-1 drugs age less quickly ...

The drugs cause weight loss by stimulating a receptor, GLP-1, that tells your brain you’re not hungry. Yet real-world studies ...

Each year, MIT Technology Review puts together a list of the most promising climate tech companies in the world. This year, ...

Beijing, China. Your daily dose of what's up in emerging technology Founded at the Massachusetts Institute of Technology in 1899, MIT Technology Review is a world-renowned, independent media company ...

Form Energy is building iron-based batteries that can store energy for multiple days. The company is ramping up supply at its ...